159 phenotypes from 8 alleles in 7 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Fshrtm1(KOMP)Vlcg/Fshrtm1(KOMP)Vlcg C57BL/6N-Fshrtm1(KOMP)Vlcg/Nju	abnormal startle reflex	J:211773
	decreased bone mineral content	J:211773
	decreased bone mineral density	J:211773
	decreased lean body mass	J:211773
	increased fasting circulating glucose level	J:211773
	increased total body fat amount	J:211773
Fshrtm1Hht/Fshr+ involves: 129S7/SvEvBrd	ovary hemorrhage	J:160015
Fshrtm1Hht/Fshrtm1Hht involves: 129S7/SvEvBrd	ovary hemorrhage	J:160015
Fshrtm1Mha/Fshrtm1Mha involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal ovary morphology	J:61909
	abnormal testes secretion	J:61909
	absent corpus luteum	J:61909
	absent estrous cycle	J:61909
	absent mature ovarian follicles	J:61909
	decreased ovary secretion	J:61909
	decreased ovary weight	J:61909
	decreased testis weight	J:61909
	decreased uterus weight	J:61909
	female infertility	J:61909
	impaired ovarian folliculogenesis	J:61909
	increased circulating follicle stimulating hormone level	J:61909
	increased circulating luteinizing hormone level	J:61909
	increased follicle stimulating hormone level	J:61909
	small ovary	J:61909
	small seminiferous tubules	J:61909
	uterus atrophy	J:61909
	vagina atresia	J:61909
Fshrtm1Saco/Fshr+ involves: 129	abnormal estrous cycle	J:140008
	abnormal estrus	J:65577
	abnormal female germ cell morphology	J:140008
	abnormal granulosa cell morphology	J:140008
	abnormal ovarian follicle number	J:140008
	abnormal ovarian folliculogenesis	J:140008
	abnormal ovary physiology	J:140008
	absent corpus luteum	J:140008
	absent estrous cycle	J:140008
	absent oocytes	J:140008
	decreased circulating progesterone level	J:65577
	decreased litter size	J:65577, J:140008
	decreased primary ovarian follicle number	J:140008
	delayed female fertility	J:65577
	early reproductive senescence	J:65577, J:140008
	early vaginal opening	J:140008
	female infertility	J:65577
	hunched posture	J:65577
	increased apoptosis	J:140008
	increased body weight	J:65577, J:140008
	increased circulating testosterone level	J:65577
	increased follicle recruitment	J:140008
	increased ovary tumor incidence	J:140008
	kyphosis	J:65577
	long gestation period	J:140008
	neonatal lethality, complete penetrance	J:140008
	obese	J:65577, J:140008
	oocyte degeneration	J:140008
	ovary cyst	J:70933, J:140008
	polyovular ovarian follicle	J:140008
	postnatal lethality, incomplete penetrance	J:140008
	premature aging	J:65577
	prolonged diestrus	J:65577
	prolonged estrous cycle	J:65577, J:140008
	reduced female fertility	J:140008
Fshrtm1Saco/Fshr+ involves: 129T2/SvEmsJ	abnormal dentate gyrus morphology	J:89713
	abnormal enzyme/coenzyme activity	J:89713
	abnormal ovary morphology	J:89713
	abnormal thrombosis	J:81460
	abnormal uterine environment	J:81460
	abnormal uterus morphology	J:81460
	absent corpus luteum	J:89713
	absent estrous cycle	J:81460
	absent ovarian follicles	J:89713
	astrocytosis	J:89713
	decreased circulating estradiol level	J:81460, J:89713
	decreased circulating progesterone level	J:81460
	decreased litter size	J:81460
	early reproductive senescence	J:81460, J:89713
	enlarged endometrial glands	J:81460
	enlarged uterus	J:81460
	hippocampal neuron degeneration	J:89713
	increased anxiety-related response	J:89713
	increased circulating follicle stimulating hormone level	J:81460
	increased circulating luteinizing hormone level	J:81460
	increased circulating testosterone level	J:81460, J:89713
	increased thigmotaxis	J:89713
	increased uterus tumor incidence	J:81460
	increased uterus weight	J:81460
	neurodegeneration	J:89713
	ovary atrophy	J:89713
	ovary cyst	J:81460, J:89713
	premature aging	J:89713
	reduced female fertility	J:81460
	uterine hemorrhage	J:81460
	uterus adenomyosis	J:81460
	uterus cyst	J:81460
Fshrtm1Saco/Fshr+ involves: C57BL/6	abnormal male germ cell morphology	J:61957
	abnormal sperm physiology	J:61957
	abnormal spermiogenesis	J:61957
	decreased circulating testosterone level	J:50933
	decreased litter size	J:50933
	increased circulating follicle stimulating hormone level	J:50933
	reduced female fertility	J:50933
	reduced male fertility	J:50933
	small ovary	J:50933
	small uterus	J:50933
Fshrtm1Saco/Fshrtm1Saco involves: 129	abnormal abdominal fat pad morphology	J:65577
	abnormal corpus epididymis morphology	J:137005
	abnormal endometrial gland morphology	J:65577
	abnormal epididymis epithelium morphology	J:137005
	abnormal estrous cycle	J:65577
	abnormal ovary morphology	J:65577, J:70933
	abnormal sperm axoneme morphology	J:137005
	abnormal sperm head morphology	J:137005
	abnormal sperm nucleus morphology	J:137005
	abnormal spermatid morphology	J:70680
	abnormal spermatogonia proliferation	J:70680
	abnormal spermiogenesis	J:70680
	abnormal testis development	J:70680
	abnormal thoracic vertebrae morphology	J:65577
	abnormal uterus morphology	J:65577
	abnormal vagina epithelium morphology	J:65577
	abnormal vagina orifice morphology	J:65577
	absent corpus luteum	J:65577, J:70933
	absent estrous cycle	J:65577, J:70933
	absent mature ovarian follicles	J:65577
	anemia	J:70933
	anovulation	J:70933
	asthenozoospermia	J:137005
	cachexia	J:70933
	calcinosis	J:70933
	decreased bone mineral density of femur	J:65577
	decreased circulating estradiol level	J:65577, J:70933
	decreased circulating progesterone level	J:65577
	decreased circulating testosterone level	J:70680
	decreased epididymis weight	J:70680
	decreased femur weight	J:65577
	decreased litter size	J:70680
	decreased ovary weight	J:65577
	decreased Sertoli cell number	J:70680
	decreased testis weight	J:70680
	decreased uterus weight	J:65577
	decreased vagina weight	J:65577
	delayed male fertility	J:70680
	delayed sexual maturation	J:70680
	detached acrosome	J:137005
	enlarged clitoris	J:65577
	enlarged spleen	J:70933
	female infertility	J:70933
	hunched posture	J:65577
	impaired ovarian folliculogenesis	J:70933
	increased body weight	J:65577
	increased circulating follicle stimulating hormone level	J:70933
	increased circulating luteinizing hormone level	J:70933
	increased circulating testosterone level	J:65577, J:70933
	increased follicle stimulating hormone level	J:70933
	increased luteinizing hormone level	J:70933
	increased ovarian carcinoma incidence	J:70933
	increased pre-B cell number	J:65577
	increased total fat pad weight	J:65577
	kyphosis	J:65577
	myometrium hypoplasia	J:65577
	obese	J:65577, J:70933
	oligozoospermia	J:137005
	ovary cyst	J:70933
	pallor	J:70933
	reduced male fertility	J:70680
	small caput epididymis	J:137005
	small ovary	J:70933
	small seminiferous tubules	J:70680
teratozoospermia	J:137005
thin uterus	J:65577
uterus atrophy	J:65577
vagina atrophy	J:65577
weight loss	J:70933
Fshrtm1Saco/Fshrtm1Saco involves: C57BL/6	abnormal caput epididymis morphology	J:61957
	abnormal epididymis morphology	J:61957
	abnormal ovarian folliculogenesis	J:50933
	abnormal seminiferous tubule epithelium morphology	J:50933, J:61957
	abnormal seminiferous tubule morphology	J:50933
	abnormal sperm flagellum morphology	J:50933, J:61957
	abnormal sperm physiology	J:61957
	abnormal spermatid morphology	J:61957
	abnormal spermatogenesis	J:50933, J:61957
	abnormal spermatogonia morphology	J:61957
	abnormal spermiogenesis	J:61957
	abnormal testis size	J:50933
	absent corpus luteum	J:50933
	absent mature ovarian follicles	J:50933
	adenohypophysis hyperplasia	J:50933
	anovulation	J:50933
	asthenozoospermia	J:50933, J:61957
	decreased circulating testosterone level	J:50933, J:61957
	decreased epididymis weight	J:61957
	decreased seminal vesicle weight	J:61957
	decreased testis weight	J:61957
	enlarged sperm head	J:61957
	female infertility	J:50933
	impaired ovarian folliculogenesis	J:50933
	increased circulating follicle stimulating hormone level	J:50933
	increased gonadotroph cell number	J:50933
	increased thyrotroph cell number	J:50933
	kinked sperm flagellum	J:61957
	oligozoospermia	J:50933
	reduced male fertility	J:50933, J:61957
	small epididymis	J:61957
	small ovary	J:50933
	small seminal vesicle	J:50933, J:61957
	small seminiferous tubules	J:50933, J:61957
	small testis	J:50933
	small uterus	J:50933
	thin uterus	J:50933
Tg(AMH-Fshr)27Hht/0 involves: FVB/N	increased ovarian teratoma incidence	J:160015
	ovary hemorrhage	J:160015
Tg(AMH-Fshr*D580H)14Hht/0 involves: FVB/N	decreased circulating follicle stimulating hormone level	J:160015
	decreased circulating luteinizing hormone level	J:160015
	increased circulating estradiol level	J:160015
	increased circulating prolactin level	J:160015
Tg(AMH-Fshr*D580H)#Hht/0 involves: FVB/N	abnormal adrenal gland morphology	J:160015
	abnormal estrous cycle	J:160015
	abnormal fertility/fecundity	J:160015
	abnormal mammary gland morphology	J:160015
	abnormal ovarian follicle number	J:160015
	abnormal ovary morphology	J:160015
	abnormal ovulation	J:160015
	abnormal proestrus	J:160015
	absent estrous cycle	J:160015
	absent estrus	J:160015
	decreased luteinizing hormone level	J:160015
	female infertility	J:160015
	increased cell proliferation	J:160015
	increased granulosa cell proliferation	J:160015
	increased litter size	J:160015
	increased ovarian carcinoma incidence	J:160015
	increased ovarian teratoma incidence	J:160015
	increased pituitary gland weight	J:160015
	increased prolactin level	J:160015
	increased prolactinoma incidence	J:160015
	ovary hemorrhage	J:160015
	pituitary gland hyperplasia	J:160015
	reduced female fertility	J:160015
Tg(AMH-Fshr*D580Y)#Hht/0 involves: FVB/N	increased ovarian teratoma incidence	J:160015
	ovary hemorrhage	J:160015